Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Vigdis Lauvrak"'
Autor:
Julia Bidonde, Vigdis Lauvrak, Aparna Ananthakrishnan, Pritaporn Kingkaew, Elizabeth F. Peacocke
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Background There is limited evidence-informed guidance on TISP processes for countries where health technology assessment (HTA) is in a nascent phase. We aimed to explore the range of topic identification, selection and prioritization (TISP)
Externí odkaz:
https://doaj.org/article/a70e4e33ebe940fe8e376512f0d54b87
Autor:
Vigdis Lauvrak, Kelly Farrah, Leigh-Ann Topfer, Ingrid Harboe, Elisabet Hafstad, Rosmin Esmail, Anna Lien Espeland, Antonio Migliore, Ingrid Kristine Ohm
Publikováno v:
International Journal of Technology Assessment in Health Care. 37
Objective In 2019, members of the Health Technology Assessment international (HTAi) Interest Group for Disinvestment and Early Awareness (DEA-IG) and the HTAi Interest Group for Information Retrieval (IR-IG) agreed to produce quarterly current awaren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::397ffb27391527c335d44c9212bd9e3b
https://doi.org/10.1017/s0266462321000568
https://doi.org/10.1017/s0266462321000568
Autor:
Vigdis Lauvrak, Anna Lien Espeland, Elisabet Hafstad, Antonio Migliore, Leigh-Ann Topfer, Ingrid Kristine Ohm, Ingrid Harboe, Kelly Farrah, Rosmin Esmail
Publikováno v:
International Journal of Technology Assessment in Health Care. 36:10-10
IntroductionIn 2019, the Norwegian Institute for Public Health and Canadian Agency for Drugs and Technologies in Health (CADTH) received support from HTAi to produce a quarterly current awareness alert for the HTAi Disinvestment and Early Awareness I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff3ecf0fe5d1d9b4a27d873ceccbd67a
https://doi.org/10.1017/s0266462320001130
https://doi.org/10.1017/s0266462320001130
Autor:
Helene, Arentz-Hansen, Elisabet, Hafstad, Vigdis, Lauvrak, Anna, Stoinska-Schneider, Vidar Jusnes, Vang, Sari, Ormstad, Brynjar, Fure
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 138(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::68fbdd7ef3ea24f0000bf01090c4d108
https://pubmed.ncbi.nlm.nih.gov/29808662
https://pubmed.ncbi.nlm.nih.gov/29808662
Autor:
Sune Justesen, Muluneh Bekele Daba, Burkhard Fleckenstein, Inger Sandlie, Gøril Berntzen, Terje E. Michaelsen, Vigdis Lauvrak, Jan Terje Andersen, Søren Buus, Vania E. Kenanova
Publikováno v:
FEBS Journal. 275:4097-4110
The neonatal Fc receptor (FcRn) is a major histocompatibility complex class I-related molecule that regulates the half-life of IgG and albumin. In addition, FcRn directs the transport of IgG across both mucosal epithelium and placenta and also enhanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c35081359050bae22dea05f050209e1
https://doi.org/10.1111/j.1742-4658.2008.06551.x
https://doi.org/10.1111/j.1742-4658.2008.06551.x
Autor:
Vigdis Lauvrak, Terje E. Michaelsen, S.A. Mousavi, O.H. Brekke, Jan Terje Andersen, Gøril Berntzen, Inger Sandlie, T. Berg
Publikováno v:
Protein Engineering, Design and Selection. 19:121-128
The high-affinity IgG receptor, Fcgamma receptor I (FcgammaRI), is expressed exclusively on myeloid cells, and there is a great interest in the targeting of vaccine antigens to FcgammaRI using anti-human FcgammaRI antibodies or fragments derived from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23f11a87061a2e4985b667e365c55e84
https://doi.org/10.1093/protein/gzj011
https://doi.org/10.1093/protein/gzj011
Autor:
Jan Terje Andersen, Elin Lunde, Morten Flobakk, Gøril Berntzen, Vigdis Lauvrak, Inger Sandlie
Publikováno v:
Journal of Immunological Methods. 298:93-104
In studies of the relation between structure and function of proteins of the immune system, there is a continuous need for screening of a large number of protein variants. To optimise the yield following transient gene expression in small or medium c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c1b18a58576dff1d6c037b82ffce28e
https://doi.org/10.1016/j.jim.2005.01.002
https://doi.org/10.1016/j.jim.2005.01.002
Autor:
Randi Sandin, R. Dalseg, U. Heggelund, T. K. Herstad, Inger Sandlie, Terje E. Michaelsen, Gøril Berntzen, Vigdis Lauvrak, Einar Rosenqvist
Publikováno v:
Scandinavian Journal of Immunology. 59:373-384
There is still no general vaccine for prevention of disease caused by group-B meningococcal strains. Meningococcal lipopolysaccharides (LPSs) have received attention as potential vaccine candidates, but concerns regarding their safety have been raise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f1cf869bfa2e8eb6616cccb83cbddd
https://doi.org/10.1111/j.1365-3083.2004.01400.x
https://doi.org/10.1111/j.1365-3083.2004.01400.x
Autor:
Elin Lunde, Ingunn B. Rasmussen, I. Sandlie, K. M. Thompson, Vigdis Lauvrak, Terje E. Michaelsen, B. Bogen, O.H. Brekke, Ludvig M. Sollid, K. W. Schjetne
Publikováno v:
Biochemical Society Transactions. 30:500-506
All antibodies (Abs) with effector function are produced in mammalian cells, whereas bacterial production is restricted to smaller targeting fragments (scFv and Fab) without effector functions. In this project, we isolated different peptides that bin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30a5e187d230b5939ef272e8f2c4ba08
https://doi.org/10.1042/bst0300500
https://doi.org/10.1042/bst0300500
Publikováno v:
International Journal of Technology Assessment in Health Care. 33:115-115
INTRODUCTION:Multiple Sclerosis (MS) is an inflammatory neurological disease. The standard treatment is disease modifying drugs which may alleviate symptoms and slow the progress of disability, but not lead to remission. Autologous Hematopoetic Stem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68c643be747bbf4739ed717e256769c1
https://doi.org/10.1017/s0266462317002598
https://doi.org/10.1017/s0266462317002598